BFRI (Biofrontera Inc. Common Stock) Stock Analysis

Biofrontera Inc. Common Stock (BFRI) is a publicly traded Healthcare sector company. As of May 21, 2026, BFRI trades at $0.82 with a market cap of $9.54M and a P/E ratio of -0.77. BFRI moved +0.51% today. Year to date, BFRI is +1.23%; over the trailing twelve months it is +22.43%. Its 52-week range spans $0.54 to $2.22. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces BFRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest BFRI stock research?

Biofrontera Inc. Common Stock (BFRI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BFRI moved +0.51% today. Analyst consensus is buy.

BFRI Key Metrics

Key financial metrics for BFRI
MetricValue
Price$0.82
Market Cap$9.54M
P/E Ratio-0.77
EPS$-1.04
Dividend Yield0.00%
52-Week High$2.22
52-Week Low$0.54
Volume102.24K
Avg Volume0
Revenue (TTM)$41.70M
Net Income$-10.54M
Gross Margin0.00%

Latest BFRI News

BFRI Analyst Consensus

1 analysts cover BFRI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about BFRI

What can I research for BFRI on Rallies?
Biofrontera Inc. Common Stock (BFRI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BFRI moved +0.51% today. Analyst consensus is buy.
Does Rallies show live market data for BFRI?
Rallies combines live market context with ticker research for BFRI, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
BFRI

BFRI